[Judicial judgment for severe adverse drug reaction (ADR)].
Iijima
Masafumi
M
Department of Dermatology, Showa University, School of Medicine. miijima@med.showa-u.ac.jp
D002983:Clinical Competence / Q000331:legislation & jurisprudence*; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects; D016365:Liability, Legal; D008318:Malpractice / Q000331:legislation & jurisprudence*; D010634:Phenobarbital / Q000009:adverse effects; D012017:Referral and Consultation / Q000331:legislation & jurisprudence*; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced* / Q000209:etiology*
D007213:Indomethacin; D010634:Phenobarbital